Clinical Trials

Inclusion Criteria:

• Multiple Myeloma diagnosis
• Females and males ≥60 years of age
• ECOG score of <3
• Scheduled for a CAR T Therapy transfusion
• Apheresis date at least 7 days prior to date of enrollment
• Primary hematologist attending physician clearance for exercise

Exclusion Criteria: 

• Females or males <60 years of age
• Any hematological cancer other than multiple myeloma
• Evidence of an absolute contraindication (eg, heart insufficiency >NYHA III or uncertain arrhythmia; uncontrolled hypertension; reduced standing or walking ability for exercise).
• Other comorbidities that preclude participation in the exercise as deemed by physical therapist or PM&R physician.
• Active infections, active bleeding disorders, and cytopenias at risk for further adverse events deemed by hematologist-oncologist

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 02/25/2025. Questions regarding updates should be directed to the study team contact.